Skip to main content
All lobbying clients

ABBOTT LABORATORIES

Lobbying client · District of Columbia · filed 2025 to 2026

Leader in disease prevention, care, management, testing, and other global health issues.

$10,962,496 Reported spend
75 Filings counted
12 Outside firms hired
27 Bills named

Spend is reported income plus in-house expenses across 75 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 13 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 13

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 27
  • H.R. 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and fo…
    18 filings
  • S. 3387
    Ensuring Safe and Toxic-Free Foods Act of 2023
    4 filings
  • S. 2003
    Strengthening Benefit Plans Act of 2025
    4 filings
  • S. 2426
    Equitable Community Access to Pharmacist Services Act
    4 filings
  • H.R. 1770
    Equitable Community Access to Pharmacist Services Act
    3 filings
  • H.R. 1835
    Saving Access to Laboratory Services Act
    3 filings
  • H.R. 9817
    Toxic Free Food Act of 2024
    3 filings
  • S. 1000
    Saving Access to Laboratory Services Act
    3 filings
  • S. 2477
    Equitable Community Access to Pharmacist Services Act
    3 filings
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
    3 filings
  • H.R. 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
    3 filings
  • S. 1821
    Tackling Predatory Litigation Funding Act
    3 filings
  • H.R. 3512
    Tackling Predatory Litigation Funding Act
    2 filings
  • H.R. 4779
    National Security, Department of State, and Related Programs Appropriations Act, 2026
    2 filings
  • H.R. 4958
    GRAS Act
    2 filings
  • H.R. 8595
    National Security, Department of State, and Related Programs Appropriations Act, 2027
    2 filings
  • H.R. 7164
    Advancing Research for Chronic Pain Act of 2024
    1 filing
  • S. 2922
    Advancing Research for Chronic Pain Act of 2023
    1 filing
  • H.R. 5269
    RESULTS Act
    1 filing
  • H.R. 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    1 filing
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026
    1 filing
  • H.R. 7966
    Hospice CARE Act of 2026
    1 filing
  • H.R. 8845
    Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
    1 filing
  • S. 2761
    RESULTS Act
    1 filing
  • S. 4118
    Hospice CARE Act of 2026
    1 filing
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
    1 filing
  • S. 4940
    Specialized Infant Formula Protection Act
    1 filing
 Reported by year 2 years
  • 2026 $4,990,000 35 filings
  • 2025 $5,972,496 40 filings
 Issues lobbied 16
 Agencies and chambers lobbied 18
  • HOUSE OF REPRESENTATIVES 47
  • SENATE 45
  • Health & Human Services, Dept of (HHS) 14
  • Food & Drug Administration (FDA) 10
  • U.S. Trade Representative (USTR) 9
  • State, Dept of (DOS) 5
  • White House Office 5
  • Centers For Medicare and Medicaid Services (CMS) 4
  • Commerce, Dept of (DOC) 3
  • Office of Management & Budget (OMB) 3
  • Veterans Affairs, Dept of (VA) 3
  • Agriculture, Dept of (USDA) 2
  • Treasury, Dept of 2
  • Agency for Healthcare Research & Quality (AHRQ) 1
  • Executive Office of the President (EOP) 1
  • Natl Economic Council (NEC) 1
  • Office of Science & Technology Policy (OSTP) 1
  • U.S. Customs & Border Protection 1
 Recent filings 75 total
Q3 report
PHRONESISDC, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
DUDDINGTON GLOBAL STRATEGIES LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
THE DUBERSTEIN GROUP INC.
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
ABBOTT LABORATORIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $1,300,000 expenses · posted Oct 20, 2026
View →
Q3 report
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2026 (July 1 - Sep 30) · $60,000 income · posted Oct 20, 2026
View →
Registration
THE DUBERSTEIN GROUP INC.
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 reportNo activity
FEDERAL HEALTH POLICY STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 19, 2026
View →
Q3 report
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 18, 2026
View →
Q3 report
S-3 GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 16, 2026
View →
Q3 reportNo activity
MAYER BROWN LLP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 16, 2026
View →
Registration
DUDDINGTON GLOBAL STRATEGIES LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 14, 2026
View →
Q3 report
KOUNTOUPES DENHAM CARR & REID, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 6, 2026
View →
Q2 report
ABBOTT LABORATORIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,150,000 expenses · posted Jul 20, 2026
View →
Q2 report
MAYER BROWN LLP
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 20, 2026
View →
Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · $50,000 income · posted Jul 20, 2026
View →
Q2 report
AKIN GUMP STRAUSS HAUER & FELD
2nd Quarter 2026 (Apr 1 - June 30) · $60,000 income · posted Jul 20, 2026
View →
Q2 report
PHRONESISDC, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 reportNo activity
FEDERAL HEALTH POLICY STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 20, 2026
View →

Showing the 20 most recent of 75 filings. Search the explorer for "ABBOTT LABORATORIES".

 Affiliated organisations 1
  • EXACT SCIENCES CORPORATION United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem